Supplementary Figure S1 from ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell–mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer Models

Abstract

<p>Supplementary Figure 1 shows characterization of ZL-1211.</p>